• search

Aurobindo gets nod for Cefuroxime Axetil Tablets

Written by: Staff

Mumbai, April 3 (UNI) Aurobindo Pharma today announced that it has received approval for Cefuroxime Axetil Tablets USP, 125 mg (base), 250 mg (base), 500 mg (base) from US FDA.

With this Oral Cephalosporin approval, the company's product basket for the US market has increased to 13 (final approvals), it informed BSE here today, accordingly.

Apart from this, the company has 10 tentative approvals for the US market.

The size of generics business of Cefuroxime Axetil 125/ 250/ 500 mg is around USD 50 million.

Cefuroxime Axetil tablets are indicated for the treatment of patients with infections caused by susceptible strains of designated organisms in the following diseases: Pharyngitis and Tonsillitis, Lower Respiratory Tract Infections, Urinary Tract Infections and Skin Structure Infections.

Cefuroxime Axetil Tablets USP, 125 mg (base), 250 mg (base), 500 mg (base) is the generic version of Glaxo Wellcomes Ceftin.


For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more